Genetic polymorphism of merozoite surface protein 2 and prevalence of K76T pfcrt mutation in Plasmodium falciparum field isolates from Congolese children with asymptomatic infections

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Koukouikila Koussounda, Felix ^a,b,e   Malonga, Vladimir ^a   Mayengue, Pembe Issamou ^a,b   Ndounga, Mathieu ^c,d   Vouvoungui, Christevy Jeannhey ^a,b   Ntoumi, Francine ^a,b,e  

^a Congolese Foundation for Medical Research ^*  (Congo)

^b UNIVERSITÉ MARIEN NGOUABI   (Congo)

^c Centre de Recherche sur les Ressources Végétales   (Congo)

^d Makélékélé Hospital   (Congo)

^e UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Asymptomatic infection; Brazzaville; msp2; Multiplicity of infection; pfcrt; Plasmodium falciparum; Republic of Congo

Indexed keywords

MEROZOITE SURFACE PROTEIN 2; PARASITE ANTIGEN; PLASMODIUM FALCIPARUM CHLOROQUINE RESISTANCE TRANSPORTER; RESTRICTION ENDONUCLEASE; UNCLASSIFIED DRUG; CARRIER PROTEIN; MEROZOITE SURFACE PROTEIN 2, PLASMODIUM; PFCRT PROTEIN, PLASMODIUM FALCIPARUM; PROTOZOAL DNA; PROTOZOAL PROTEIN;

ALLELE; ARTICLE; CHILD; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MICROSCOPY; NONHUMAN; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SCHOOL CHILD; ASYMPTOMATIC INFECTION; COHORT ANALYSIS; CONGO; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; INFANT; ISOLATION AND PURIFICATION; MISSENSE MUTATION; PARASITEMIA; PARASITOLOGY; PATHOLOGY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ANTIGENS, PROTOZOAN; ASYMPTOMATIC INFECTIONS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CONGO; DNA, PROTOZOAN; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MEMBRANE TRANSPORT PROTEINS; MICROSCOPY; MUTATION, MISSENSE; PARASITEMIA; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTOZOAN PROTEINS;

EID: 84859098565     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-105     Document Type: Article

References (34)

1. World Health Organization, World malaria report 2010 http://Whqlibdoc. who.int/publications/2010
2. World Health Organization, World malaria report 2009 WHO/HTM/GMP/ 2009
3. Defining and defeating the intolerable burden of malaria III. Progress and perspectives. Breman JG, Alilio MS, White LJ, Am J Trop Med Hyg 2007 77 1 2 18165468
4. Insecticide-treated bed-nets for malaria mosquito control. Curtis CF, Maxwell CA, Magesa SM, Rwegoshora RT, Wilkes TJ, J Am Mosq Assoc 2006 22 501 506 10.2987/8756-971X(2006)22[501:IBFMMC]2.0.CO;2 (Pubitemid 44638425)
5. A review of malaria vaccine clinical projects based on the WHO rainbow table. Schwartz L, Brown GV, Genton B, Moorthy VS, Malar J 2012 11 11 10.1186/1475-2875-11-11 22230255
6. Age dependent carriage of multiple Plasmodium falciparum merozoite surface antigen-2 alleles in asymptomatic malaria infections. Ntoumi F, Contamin H, Rogier C, Bonnefoy S, Trape JF, Mercereau-Puijalon O, AmJTrop Med Hyg 1995 52 81 88
7. Genetic structure and dynamics of Plasmodium falciparum infections in the Kilombero region of Tanzania. Babiker HA, Ranford-Cartwright LC, Walliker D, Trans R Soc Trop Med Hyg 1999 93 11 14 10450420 (Pubitemid 29123569)
8. Epidemiology of multiple Plasmodium falciparum infections. Age dependence of the multiplicity of Plasmodium falciparum infections and other malariological indices in an area of high endemicity. Smith T, Beck HP, Kitua A, Mwankusye S, Feldrl I, Fraser-Hurt N, Irion A, Alonso P, Teuscher T, Tanner M, Trans R Soc Trop Med Hyg 1999 93 15 20 10492779 (Pubitemid 29123570)
9. Multiplicity of Plasmodium falciparum infection in asymptomatic children in Senegal: relation to transmission, age and erythrocyte variants. Vafa M, Troye-Blomberg M, Anchang J, Garcia A, Migot-Nabias F, Malar J 2008 7 17 10.1186/1475-2875-7-17 18215251 (Pubitemid 351378200)
10. Plasmodium falciparum: sickle-cell trait is associated with higher prevalence of multiple infections in Gabonese children with asymptomatic infections. Ntoumi F, Mercereau-Puijalon O, Ossari S, Luty A, Reltien J, Georges A, Millet P, Exp Parasitol 1997 87 39 46 10.1006/expr.1997.4173 9287956 (Pubitemid 27394663)
11. Criteria for diagnosing clinical malaria among a semi-immune population exposed to intense and perennial transmission. Trape JF, Peelman P, Morault-Peelman B, Trans R Soc Trop Med Hyg 1985 79 435 442 10.1016/0035- 9203(85)90054-9 3909550
12. Malaria and urbanization in the central Africa: the example of Brazzaville. Part V: Pernicious attacks and mortality. Trape JF, Quinet MC, Nzingoula S, Senga P, Tchichelle F, Carme B, Candito D, Mayanda H, Zoulani A, Trans R Soc Trop Med Hyg 1987 81 34 42 3455565 (Pubitemid 18056970)
13. Problématique de l'accès des populations de la ville de Brazzaville aux combinaisons base d'artémisinine. Trapsida JM, Mankele R, Nzébélé P, Okono G, WHO, The African Health Monitor 2010 12
14. Re-emergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. Kublin JG, Cortese JF, Njunju EM, Mukadam RA, Wirima JJ, Kazembe PN, Djimdé AA, Kouriba B, Taylor TE, Plove CV, J Infect Dis 2003 187 1870 1875 10.1086/375419 12792863 (Pubitemid 36724485)
15. Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi. Mita T, Kaneko A, Lum JK, Bwijo B, Takechi M, Zungu IL, Tsukahara T, Tanabe K, Kobayakawa T, Björkman A, AmJTrop Med Hyg 2003 68 413 415 (Pubitemid 38230640)
16. Return of chloroquine antimalarial efficacy in Malawi. Laufer MK, Thesing PC, Eddington ND, Masonga R, Dzinjalamala FK, Takala SL, Taylor TE, Plowe CV, N Engl J Med 2006 355 1959 1966 10.1056/NEJMoa062032 17093247 (Pubitemid 44708015)
17. Site-based study on polymorphism of Plasmodium falciparum MSP-1 and MSP-2 genes in isolates from two villages in central Africa. Ntoumi F, Ngoundou-Langji J, Lekoulou F, Luty A, Deleron P, Ringwald P, Parasitologia 2000 42 197 203
18. In vivo chloroquine resistance and prevalence of the pfcrt codon 76 mutation in Plasmodium falciparum isolates from the republic of Congo. Mayengue PI, Ndounga M, Davy MM, Tandou N, Ntoumi F, Acta Trop 2007 95 219 225
19. A molecular marker for chloroquine-resistant falciparum malaria. Djimdé A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV, Coulibaly D, N Engl J Med 2001 344 257 263 10.1056/NEJM200101253440403 11172152 (Pubitemid 32108530)
20. Prevalence of the K76T mutation in the putative Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene and its relation to chloroquine resistance in Mozambique. Mayor AG, Gomez-Olive X, Aponte JJ, Casimiro S, Mabunda S, Dgedge M, Barreto A, Alonso PL, J Infect Dis 2001 183 1413 1416 10.1086/319856 11294676 (Pubitemid 32337127)
21. Allele-specific enzymatic amplification of -globin genomic DNA for diagnosis of sickle cell anemia. Wu YD, Ugozzoli L, Pal BK, Wallace BR, Proc Natl Acad Sci USA 1989 86 2757 2760 10.1073/pnas.86.8.2757 2704745 (Pubitemid 19112620)
22. Plasmodium falciparum: distribution of msp2 genotypes among symptomatic and asymptomatic individuals from the Wosera region of Papua new Guinea. Cortés A, Mellombo M, Benet A, Lorry K, Rare L, Reeder JC, Exp Parasitol 2004 106 22 29 10.1016/j.exppara.2004.01.010 15013785 (Pubitemid 38317195)
23. Prevalence of Plasmodium falciparum in asymptomatic rural Gabonese populations. Nkoghe D, Akue JP, Gonzalez JP, Leroy EM, Malar J 2011 10 33 10.1186/1475-2875-10-33 21306636
24. Human genetic polymorphisms and asymptomatic Plasmodium falciparum malaria in Gabonese schoolchildren. Mombo LE, Ntoumi F, Bisseye C, Ossari S, Lu CY, Nagel RL, Krishnamoorthy R, AmJTrop Med Hyg 2003 68 186 190 (Pubitemid 38240544)
25. Plasmodium falciparum genotype population dynamics in asymptomatic children from Senegal. Jafari-Guemouri S, Boudin C, Fievet N, Ndiaye P, Deloron P, Microbes Infect 2006 8 1663 1670 10.1016/j.micinf.2006.01.023 16730211 (Pubitemid 44144561)
26. Multiplicity of Plasmodium falciparum infection following intermittent preventive treatment in infants. Buchholz U, Kobbe R, Danquah I, Zanger P, Reither K, Abruquah HH, Grobusch MP, Ziniel P, May J, Mockenhaupt FP, Malar J 2010 9 244 10.1186/1475-2875-9-244 20796302
27. Extensive dynamics of Plasmodium falciparum densities, stages and genotyping profiles. Färnert A, Lebbad M, Faraja L, Rooth I, Malar J 2008 7 241 10.1186/1475-2875-7-241 19025582
28. Plasmodium falciparum population dynamics during the early phase of anti-malarial treatment in Tanzanian children with acute uncomplicated malaria. Carlsson AM, Ngasala BE, Dahlström S, Membi C, Veiga IM, Rombo L, Abdullah S, Premji Z, Gil PJ, Björkman A, Martensson A, Malar J 2011 10 380 10.1186/1475-2875-10-380 22185672
29. Genetic polymorphisms of merozoite surface protein-1 and surface protein-2 in Plasmodium falciparum isolates from Brazzaville. Pembe IM, Ndounga M, Malonga FV, Bitemo M, Ntoumi F, Republic of Congo Malar J 2011 10 276
30. Typing of field isolates of Plasmodium falciparum. Contamin H, Fandeur T, Bonnefoy S, Skouri F, Ntoumi F, Mercereau-Puijalon O, J Clin Microbiol 1996 33 944 951
31. Genotyping of Plasmodium falciparum infections by PCR: a comparative multicentre study. Farnert A, Arez AP, Babiker HA, Beck HP, Benito A, Björkman A, Bruce MC, Conway DJ, Day KP, Henning L, Mercereau-Puijalon O, Ranford-Cartwrigth LC, Rubio JM, Snounou G, Walliker D, Zwetyanga J, Do Rosario VE, Trans R Soc Trop Med Hyg 2001 95 225 232 10.1016/S0035-9203(01)90175-0 11355566 (Pubitemid 34947393)
32. Variation of Plasmodium falciparum msp1 block2 and msp2 allele prevalence and of infection complexicty in two neighbouring Senegalese villages with different transmission conditions. Konate L, Zwetyenga J, Rogier C, Bischoff E, Fontenille D, Tall A, Spiegel A, Trape JF, Mercereau-Puijalon O, Trans R Soc Trop Med Hyg 1999 93 21 28 10492780 (Pubitemid 29123571)
33. A requiem for chloroquine. Hasting IM, Bray PG, Ward SA, Science 2002 298 74 75 10.1126/science.1077573 12364772
34. Prevalence of molecular marker of chloroquine resistance (pfcrt 76) in Nigeria 5 years after withdrawal of the drug as first-line antimalaria: A cross-sectional study. Efunshile M, Runsewe-Abiodum T, Ghebremedhin B, König W, König B, SA J Child Health 2011 5 39 41